Dr. Rohit Dhall, MD

Dr. Dhall practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Dhall's NPI, 1699982884, was assigned on May 17, 2007. Dr. Dhall holds Arizona license 41581.

Dr. Dhall's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Dr. Dhall's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. Dr. Dhall is also affiliated with Baptist Health Rehabilitation Institute-Little Rock. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Dhall to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dhall practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Dhall's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Dhall is licensed in Arizona.

CMS data shows 368 Medicare services from Dr. Dhall across 7 procedure codes in 2024, for 287 Medicare patients. Medicare paid $29,622 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 287 Medicare patients who saw Dr. Dhall in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dhall's median patient age at 69, with 52% women.

In 2024, Dr. Dhall wrote 2,203 Medicare Part D claims for 322 patients. 80% of them were for generic drugs. CMS names the drug for 1,938 of them, across 45 drugs with 11 or more claims each, at $1,531,958 in total drug cost. In 2023, CMS named 1,854 claims across 42 drugs.

Dr. Dhall accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 84 general payments to Dr. Dhall from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Impax Laboratories, Inc. paid the most, $11,762. It also lists 5 research payments totaling $63,682 in 2025.